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Abstract
Background: Colectomy remains a treatment option for a minority of patients with slow-transit constipation (STC) refractory to con-
servative treatment. However careful patient selection is essential to maximize benefits and minimize risk of adverse outcome. This
study determined the proportion of patients with chronic constipation that would meet criteria for colectomy based on recent
European graded practice recommendations derived by expert consensus.
Methods: Retrospective application of graded practice recommendations was undertaken on a prospectively maintained data set of
consecutive adult patients with chronic constipation who underwent whole-gut transit studies using radio-opaque markers. Primary
analysis applied contraindications achieving high level of expert consensus (normal whole-gut transit as an absolute contraindica-
tion and faecal incontinence as a relative contraindication for colectomy). Secondary analysis applied contraindications with less
certain consensus.
Results: Primary analysis of 1568 patients undergoing a whole-gut transit study between January 2004 and March 2016 found 208
(13.3 per cent) met published criteria to be selected for colectomy, with 974 excluded for normal whole-gut transit and 386 for faecal
incontinence. Secondary analysis demonstrated high prevalence of other relative contraindications to colectomy: 165 concomitant
upper gastrointestinal symptoms, 216 abdominal pain (including 126 irritable bowel syndrome), and 446 evacuation disorder. The
majority of patients (416 of 594) had two or more relative contraindications. If these patients were excluded, only 26 (1.7 per cent)
chronically constipated patients retrospectively met selection criteria for colectomy.
Conclusions: The retrospective application of selection criteria is a limitation. However, the data highlight the high prevalence of fac-
tors associated with poor postoperative outcome and provide further caution to surgeons undertaking colectomy for STC.
Introduction
Colectomy remains a treatment option for patients with slow-
transit constipation (STC) who have no palliation of symptoms
after non-surgical attempts. The concept of shortening a dysmo-
tile large bowel to effect an improvement in symptoms is a long-
standing approach1, but there is a dichotomy between the
good results from some single-centre case series2–4, and those
reported by others where outcomes reflect a balance of benefits
and significant short- and long-term harms (including some very
poor functional outcomes)5,6. Further, there is uncertainty in
terms of extent of resection (total or subtotal) and type of anasto-
mosis6.
In 2017, a UK-funded programme of research (NIHR
CapaCiTY) systematically reviewed all major procedures for
patients with chronic constipation. Five reviews, including one
focused on colectomy6, provided summary evidence statements
in regard to benefits and harms based on data synthesis. These
were combined to produce graded practice recommendations7
derived by European Expert Consensus using Delphi techniques.
With the caveat that poor data quality limited firm conclusions,
criteria for patient selection (based on the effect of baseline
patient characteristics on surgical outcome) were also docu-
mented for all main procedures. These included confirmation of
diagnosis (that is, STC) and a number of relative and absolute
contraindications (Table S1).
This poses the question of how many patients would be
deemed appropriate for consideration for colectomy after such
criteria were rigorously applied in practice. The aim of this study
was to apply these selection criteria retrospectively to a cohort of
consecutive patients referred with chronic constipation to a UK
specialist surgical service to determine specifically the proportion
of patients with STC and the proportions of patients with abso-




A prospectively maintained data set of consecutive patients, aged
between 18 and 80 years, referred to the Royal London Hospital
Gastrointestinal Physiology Unit between January 2004 and
March 2016 for investigation of symptoms of bowel dysfunction,
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was analysed retrospectively. The data set consisted of informa-
tion regarding patients’ demography, bowel symptoms, medical
and surgical history, obstetric history, current and past medica-
tions and quality of life, all collected using a comprehensive
bowel symptom questionnaire that also incorporated Rome III
criteria for functional constipation and irritable bowel syndrome
(IBS)8, the Cleveland Clinic constipation9 and St Mark’s inconti-
nence scores10. Results of detailed anorectal physiological and
structural investigations, including rectal sensation to balloon
distension, anorectal manometry, defecography and whole-gut
transit studies were also available within the data set. Whole-gut
transit studies were performed in those with a history of
infrequent defecation. Patients with a primary presenting com-
plaint of constipation, who completed symptom questionnaires
and who underwent investigation of whole-gut transit study,
were included in the study. The study was qualified as exempt
from full Research Ethical Committee review, with local approval
being issued (IRAS ID 270602).
Patients’ investigations and diagnoses
Whole-gut transit was assessed using a plain abdominal
radiograph 100 hours following ingestion of capsules containing
50 1-mm polyethylene markers. Patients were defined as having
delayed whole-gut transit (STC) if 20 per cent or more of the
markers were retained at the time of the radiograph11.
Self-reported questionnaire responses included abdominal
pain, scored according to frequency (never, rarely, sometimes,
usually and always)9 and severity, using a visual analogue scale
(from 0 to 10, where 0¼none at all and 10¼ severe). IBS was clas-
sified using the Rome III criteria for IBS8. Concomitant upper gas-
trointestinal symptoms (bloating, allied to nausea or vomiting)
were also scored according to reported frequency and severity
(similar to above). Diagnosis of concomitant evacuation disorder
was based on results of barium defecography, performed in ac-
cordance with a previously published protocol12. Evacuation dis-
orders may be ‘functional’ or structural, with the former defined
by incomplete (less than 60 per cent) or prolonged (more than
150 seconds) expulsion of instilled neostool12 in the presence of
poor opening of the anorectal angle, poor relaxation of the anal
canal, or poor expulsive force generated. Structural anomalies in-
clude significant intussusception (Oxford 3–5 or obstructing
Oxford 1–2)13, ‘trapping’ rectocoele (greater than 4 cm depth or
2–4 cm with stool trapping and symptomatic)12,13, enterocoele13,
excessive dynamic perineal descent (greater than 3.5 cm)13, and
megarectum (rectal diameter greater than 8.1 cm in men and
greater than 6.9 cm in women)12. Faecal incontinence (FI) was
graded using the St. Mark’s incontinence score10. A score of 6 or
higher was considered to demonstrate significant incontinence14.
Diagnosis of a functionally impaired sphincter was made based
on anorectal manometry. Assessments performed prior to 2013
utilized a station pull-through technique using a water-perfused
manometric system (see previously published protocol and nor-
mal values from healthy subjects)15. Assessments performed
thereafter used a high-resolution anorectal manometry system
(see previously published protocol and normal values from
healthy subjects)16. Impaired sphincter function was defined as
anal hypotonia (resting tone below the lower limit of normal) or
voluntary anal hypocontractility (squeeze pressure below the
lower limit of normal)17. Upper gastrointestinal physiology stud-
ies (e.g. gastric emptying studies, prolonged small bowel manom-
etry) were not routinely performed and have not been included
as a criterion in this study.
Patients with chronic constipation who meet
published selection criteria for colectomy
Patients with contraindications to colectomy were serially ex-
cluded based on their response to the bowel symptom question-
naire and anorectal physiology results. Using the European
graded practice recommendations7 with a Delphi decision of ‘ap-
propriate’ (based on unanimity or near unanimity of consensus),
the following were applied as exclusion criteria in the primary
analysis:
• Unproven delay in whole-gut transit (absolute)
• Faecal incontinence and/or functionally impaired anal
sphincter (relative).
Recommendations with a Delphi decision of ‘uncertain’ (based
on majority consensus) were applied as exclusion criteria in the
secondary analysis:
• Concomitant significant upper gastrointestinal symptoms
(relative)
• Significant symptoms of abdominal pain and bloating (includ-
ing diagnosis of IBS) (relative)
• Concomitant untreated evacuation disorder (structural or
functional) (relative).
In addition, it was also recognized that patients who, having
passed these criteria, might be excluded for other published rea-
sons, such as major psychiatric diagnosis18–20, regular use of opi-
oid analgesia21–23, major neurological disease21,22, panenteric and
biliary dysmotility24,25 and autonomic neuropathy24,25.
Statistical analysis
Descriptive statistics were used to summarize patient characteris-
tics. Continuous and ordinal variables were described using
medians with interquartile ranges, and comparisons between two
groups made using Mann–Whitney U test. Categorical variables
were described by proportions using percentages, and comparisons
between groups made using v2 test. Grey-scale matrices represent-
ing proportion of patients reporting Cleveland Clinic Constipation
Score (CCCS) and the number of relative contraindications were
created using Microsoft Excel 2016. All statistical analyses were
performed using proprietary software (IBM SPSS Statistics for
Windows, version 25; IBM Corp., Armonk, N.Y., USA). Small inci-
dences of missing data (such as illegible entry or contradicting
responses) were excluded from individual analysis, but not consid-
ered an exclusion criterion from the whole study.
Results
Patients
Between January 2004 and March 2016, 1568 patients with symp-
toms of chronic constipation and a history of infrequent defeca-
tion underwent a whole-gut transit radio-opaque marker study,
and also completed the bowel symptom questionnaire fully
(Table 1). Overall, 974 (62.1 per cent) patients had normal whole-
gut transit, and 594 (37.9 per cent) had delayed whole-gut transit
(STC). The proportion of female patients was higher in the STC
group compared with those with normal transit (542 of 594
patients (91.2 per cent) versus 851 of 974 (87.4 per cent), respec-
tively; P¼ 0.018), otherwise demographics were similar in both
groups. Fewer patients in the STC group reported a history of pre-
vious anal or perineal surgery (88 of 594 patients (14.8 per cent)
versus 187 of 974 (19.2 per cent), respectively; P¼ 0.027), but a
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history of pelvic surgery, including hysterectomy, was greater in
the STC group (243 of 594 patients (40.9 per cent) versus 344 of
974 (35.3 per cent), P¼ 0.026). Parity, obstetric history and other
surgical history were similar in both groups. Except for symptom
of incomplete evacuation, patients with STC were more likely to
report all domains of constipation symptoms according to both
Rome III core criteria for functional constipation and the CCCS
compared with those with normal transit. Total CCCS was there-
fore higher in the STC group (median 19 (i.q.r. 15–22) versus 16
(i.q.r. 12–19), P< 0.001).
Primary analysis
Patients with chronic constipation who met published selection
criteria for colectomy with an ‘appropriate’ consensus decision are
shown in Table 2. Almost two thirds of patients with chronic consti-
pation demonstrated normal whole-gut transit (62.1 per cent),
which is an absolute contraindication for colectomy. Amongst the
594 patients with proven transit delay, a further 386 patients (65.0
per cent) had a relative contraindication for colectomy, with 330
(55.6 per cent) reporting significant symptoms of faecal inconti-
nence and 187 (31.5 per cent) demonstrating impaired anal sphinc-
ter function on manometry. A sequential selection process for
consideration of colectomy is shown using a flow diagram, which
demonstrates that only 13.3 per cent (208 out of 1568 patients)
remained appropriate for consideration for colectomy (Fig. 1).
Secondary analysis
The prevalence of other relative contraindications to colectomy
is shown in Table 3. When relative contraindications with ‘uncer-
tain’ consensus were considered, the majority of patients with
STC (416 of 594 patients, 70.0 per cent) had two or more relative
contraindications, mainly based on severe and frequent abdomi-
nal pain and concomitant upper gastrointestinal symptomology
(Fig. S1). Patients with STC demonstrated a high prevalence of ab-
dominal pain of any severity or frequency (557 of 594 patients,
93.8 per cent), with 216 (36.4 per cent) experiencing severe (VAS
of 8 or higher) and frequent (usually, always) symptoms. The
prevalence of concomitant upper gastrointestinal symptoms of
any severity or frequency were also high (407 of 594 patients, 68.5
per cent), with 165 (27.8 per cent) experiencing severe and fre-
quent symptoms. However only 126 (21.2 per cent) of these
patients met the diagnostic criteria for IBS. Evacuation disorders
were also frequent (446 of 594 patients, 75.1 per cent), with 169
(28.5 per cent) demonstrating a functional evacuation disorder
and 356 (59.9 per cent) demonstrating a structural evacuation
disorder. Co-existing functional and structural evacuation disor-
ders were found in 79 patients (13.3 per cent). Linear regression
showed a moderate but significant association between the se-
verity of constipation (CCCS) and the number of relative contra-
indications (B¼ 0.369 (95 per cent c.i. 0.061 to 0.093); P< 0.001; r2
0.136; see Fig. S2).
Table 1. Patient characteristics
Patient characteristics Normal transit(n 5 974) STC(n 5 594) P¶
Sex
Female 851 (87.4) 542 (91.2) 0.018
Male 123 (12.6) 52 (8.8)
Age (years)* 49 (37–58) 49 (37–59) 0.808#
Parity
Nulliparous 206 (24.2) 120 (22.1) 0.374
Parous 645 (75.8) 422 (77.9)
Number of deliveries†
1 113 (17.5) 61 (14.5)
2 292 (45.3) 193 (45.7)
3 137 (21.2) 94 (22.3)
4 or more 103 (16.0) 74 (17.5)
Traumatic vaginal delivery† 474 (73.5) 311 (73.7) 0.940
Instrumental delivery† 148 (22.9) 101 (23.9) 0.709
Caesarean section† 113 (17.5) 79 (18.7) 0.618
Surgical history
Abdominal or bowel surgery 278 (28.5) 165 (27.8) 0.744
Pelvic surgery, including hysterectomy 344 (35.3) 243 (40.9) 0.026
Rectal surgery 71 (7.3) 36 (6.1) 0.349
Anal or perineal surgery 187 (19.2) 88 (14.8) 0.027
Rome III core criteria for functional constipation‡
Straining 779 (80.0) 527 (88.7) <0.001
Lumpy or hard stool 175 (18.0) 244 (41.1) <0.001
Incomplete evacuation 895 (91.9) 554 (93.3) 0.318
Anorectal obstruction 701 (72.0) 488 (82.2) <0.001
Manual manoeuvres 377 (38.7) 263 (44.3) 0.029
<3 defecations per week 365 (37.5) 413 (69.5) <0.001
Cleveland Clinic constipation score§
Score* 16 (12–19) 19 (15–22) <0.001#
Frequency of bowel movement 1 per week 186 (19.1) 278 (46.8) <0.001
Painful evacuation effort 676 (69.4) 468 (78.8) <0.001
Incomplete evacuation 895 (91.9) 554 (93.3) 0.318
Abdominal pain 713 (73.2) 478 (80.5) 0.001
>10 minutes in lavatory per attempt 462 (47.4) 341 (57.4) <0.001
Assistance for defecation 597 (61.3) 420 (70.7) <0.001
>3 unsuccessful attempts per 24 hr 656 (67.4) 488 (82.2) <0.001
Duration of constipation >5 years 573 (58.8) 413 (69.5) <0.001
Values in parentheses are percentages unless indicated otherwise; *values are median (i.q.r.). †Of parous females. ‡25 per cent or more of defecations.
§Proportion of patients with a score of 2 or more per symptom category. ¶v2 test, except #Mann–Whitney U test.
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Following the inclusion of these relative contraindications in
the sequential selection process for consideration of colectomy
(Fig. 1), only 26 patients (4.4 per cent of STC patients, 1.7 per cent
of all patients with chronic constipation) remained appropriate
for consideration for colectomy. Of these, seven patients had sec-
ondary causes (opiate analgesia, concurrent psychiatric disorder
requiring medication, or significant neurological diagnosis) which
may preclude them from consideration for surgery. If a ‘lower’
bar was applied for exclusion based on severity and frequency of
abdominal pain and bloating (VAS of 4 or above and frequency of
sometimes or more often), only nine patients (1.5 per cent of STC
patients, 0.6 per cent of all patients) would have been considered
appropriate for surgery with three having secondary concerns.
Discussion
This study demonstrates that of a large starting denominator of
1568 patients with chronic constipation (severe enough to war-
rant referral to a specialist centre), only a small proportion (208
of 1568, 13.3 per cent) would retrospectively meet published
Table 2. Prevalence of contraindications to colectomy with ‘appropriate’ Delphi consensus
Absolute contraindications Frequency




Faecal incontinence or impaired sphincter function Incontinence or impaired anal sphincter function 386 (65.0)*
Incontinence (St. Mark’s incontinence score >5) 330 (55.6)*
Impaired anal sphincter function
(anal hypotonia or hypocontractility)†
187 (31.5)*
Values in parentheses are percentages. *Percentage of patients with slow transit constipation. †Normal values from healthy subject previously published by
Carrington et al.16.
Patients presented with symptoms of chronic
constipation and underwent marker studies n = 1568
Patients with normal whole gut transit excluded n = 974
Patients proven delayed whole gut transit n = 594
Excluded for faecal incontinence*
or functionally impaired sphincter† n = 386
Patients may be considered for colectomy n = 208
Excluded for moderate to
severe concomitant UGI symptoms§ n = 100
Excluded for severe and frequent
abdominal pain‡ or IBS¶ n = 46
Excluded moderate to severe
abdominal pain§ or IBS¶ n = 66
Excluded for concomitant
evacuation disorder# n = 85
Patients may be considered
of colectomy** n = 26
Patients may be considered
of colectomy** n = 9
Excluded for concomitant








Excluded for severe and frequent
concomitant UGI symptoms‡ n = 51
Fig. 1 Patient selection for colectomy
*St Mark’s incontinence score of >5. †Anal hypotonia or voluntary hypocontractility on anorectal manometry. ‡Severity of 8 or more AND frequency of 3 (usually) or
4 (always). §Severity of 4 or more AND frequency of 2 (occasionally) or above. ¶Rome III criteria for diagnosis of IBS. #Defecographic diagnosis of functional
evacuation disorder, significant intussusception, rectocoele, enterocoele, excess perineal descent and megarectum. **Information on concomitant upper
gastrointestinal (UGI) symptoms or proven UGI dysmotility not captured
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criteria7 for colectomy. The prevalence estimate of STC in the pa-
tient cohort (594 of 1568, 37.9 per cent) is consistent with previ-
ously reported rates (16–80 per cent)26–28. The new finding was
the high proportion of patients with STC who have concomitant
faecal incontinence or impaired anal sphincter function.
Colectomy is associated with a risk of diarrhoea and faecal incon-
tinence regardless of the indication for surgery29,30 due to re-
duced capacity for water absorption30, reduced absorption of
biliary acids (if terminal ileum is resected) or bacterial growth in
the ileum (if the ileocaecal valve is resected)30. Following colec-
tomy for constipation, problems of diarrhoea and incontinence
are well recognized20,31,32 and correlate with lower quality of
life29,30. Strategies to improve continence outcome included sub-
total and segmental resections33,34 but these carry an increased
risk of ongoing or recurrent constipation6,19,33. Therefore, avoid-
ance of colectomy in patients with pre-existing faecal inconti-
nence or sphincter impairment is considered prudent to
minimize the risk of postoperative new or worsening faecal in-
continence. The prevalence of faecal incontinence or sphincter
impairment among the present cohort was high (65.0 per cent).
Although the prevalence of sphincter impairment (identified on
manometry) has not been reported previously in the context of
STC, the prevalence of faecal incontinence symptoms in patients
with constipation has been reported previously by Brochard and
colleagues (24.1 per cent)35 and by Carter and colleagues (23 per
cent)36. The rate of faecal incontinence was much higher in he
present cohort (55.6 per cent), which may be attributable to the
use of different diagnostic criteria for faecal incontinence
(Cleveland Clinic incontinence score37 and Rome IV criteria for
faecal incontinence38 respectively, versus St. Mark’s incontinence
score) and variations in the denominator population.
Other relative contraindications with ‘uncertain’ consensus
decision7 were explored. After colectomy, it is well established
that symptoms of abdominal pain20,22,31,32,34 and upper gastroin-
testinal tract dysmotility (bloating, nausea, and vomit-
ing)20,22,31,34,39–41 may persist and affect functional outcome and
resultant quality of life32,39, even when relief of the constipation
symptoms has been achieved. The presence of an evacuation dis-
order may also result in persistence of constipation symptoms
and poor functional outcome following colectomy for STC31,33.
This study demonstrated a very high prevalence of abdominal
pain, symptoms of upper gastrointestinal tract dysmotility and
evacuation disorder (93.8, 68.5 and 75.1 per cent respectively)
amongst patients with STC, which may further restrict the pro-
portion of patients considered suitable for colectomy (26 of 1568,
1.7 per cent). It can also be argued that several published
exclusions were not covered by the European consensus because
insufficient data existed to do so. Thus, neurological diagno-
ses42,43, regular use of opiate medications23, major psychiatric
disorders 6,18–20,33,44 and autonomic neuropathy24,25 could be con-
sidered further causes for exclusion.
This study has two major limitations. First, it must be ac-
knowledged that the exclusion criteria applied, although derived
by several rounds of consensus (of many European experts) are
necessarily only as good as the data that underpinned their de-
velopment – which was poor. In defence, most of the criteria had
been well documented previously and accepted worldwide as
exclusions for colectomy, but this is still a limitation. Second, al-
though data collection was prospective, robust and standardized,
the presented study required the retrospective application of
European criteria. On this basis, it was not possible to derive any
meaningful analysis of the few individuals within this cohort (a
total of 6 patients) who underwent colectomy for chronic consti-
pation due to the lack of information on the reasoning behind
decisions to operate and their long-term postoperative outcomes.
Also, upper gastrointestinal dysmotility6, as well as panenteric
and biliary dysmotility24,25, are other contraindications to colec-
tomy that could not be directly evaluated as upper gastrointesti-
nal physiology studies were not routinely performed in the
authors’ chronically constipated patient cohort. In reality, other
considerations such as co-morbidities, acceptability of risks asso-
ciated with major surgery, and patients’ choice, may influence
the number of ideal patients further. However, the decision to
pursue surgery must be balanced with quality-of-life
Table 3. Prevalence of contraindications to colectomy with ‘uncertain’ Delphi consensus
Relative contraindications Frequency
Concomitant upper gastrointestinal
symptoms (bloating, nausea, vomiting)
All severity and frequency 407 (68.5)
Moderate to severe:
severity >4, frequency 2 (occasionally) or more
317 (53.4)
Severe:
severity >8, frequency 3 (usually) or 4 (always)
165 (27.8)
Abdominal pain including diagnosis of IBS All severity and frequency 557 (93.8)
Moderate to severe:
severity >4, frequency 2 (occasionally) or more)
462 (77.8)
Severe:
severity >8, frequency 3 (usually) or 4 (always)
216 (36.4)
IBS (Rome III) 126 (21.2)
Evacuation disorders All evacuation disorders
(functional, structural or both)
446 (75.1)
Functional evacuation disorder
(<60% evacuated in >150 seconds)*
169 (28.5)
Structural evacuation disorders 356 (59.9)
Significant intussusception
(Oxford 3–5 or obstructing Oxford 1–2)†
168 (28.3)
Significant rectocoele
(>4 cm or 2–4 cm with stool trapping and symptomatic)*†
184 (31.0)
Enterocoele 53 (8.9)
Excessive dynamic perineal descent (>3.5 cm)† 44 (7.4)
Megarectum (>6.9 cm in female, >8.1 cm in male)* 61 (10.3)
Values in parentheses are percentages of patients with slow transit constipation. *Normal values from healthy subject previously published by Palit et al.12. †Normal
values from healthy subject previously published by Grossi et al.13. Specific diagnosis not captured in questionnaire. IBS, irritable bowel syndrome.
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considerations given that severe constipation is significantly as-
sociated with poor quality of life35,45 and, despite the influence of
these contraindications, the reported global satisfaction ratings
from colectomy are generally high6. Other limitations include the
highly selective nature of the present sample (single-centre, ter-
tiary referral practice) that might make the results less generaliz-
able to other centres. Despite these limitations, the data provide
further caution to surgeons undertaking colectomy for STC. The
application of European recommendations to the present patient
cohort reinforces previous calls19,21,44 for very high selectivity.
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